Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity.
about
Metabotropic glutamate receptors in the basal ganglia motor circuitProgress toward therapeutic potential for AFQ056 in Fragile X syndrome.Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.Protective effect of metabotropic glutamate mGluR5 receptor elimination in a 6-hydroxydopamine model of Parkinson's disease.Mavoglurant as a treatment for Parkinson's disease.Metabotropic glutamate receptors regulate differentiation of embryonic stem cells into GABAergic neurons.Selective mGluR1 antagonist EMQMCM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus.Modulation of neurological deficits and expression of glutamate receptors during experimental autoimmune encephalomyelitis after treatment with selected antagonists of glutamate receptors.Quinolinic acid modulates the activity of src family kinases in rat striatum: in vivo and in vitro studies.Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects.Neuroprotective effects of thymosin beta4 in experimental models of excitotoxicity.Aloysia gratissima prevents cellular damage induced by glutamatergic excitotoxicity.Complex behavioral and synaptic effects of dietary branched chain amino acids in a mouse model of amyotrophic lateral sclerosis
P2860
Q28280931-C1C0EE88-76A5-4A03-A34D-66D08CD24992Q30383696-4B09393F-514F-49AA-96EA-BE2D853975B8Q30488395-14DE810E-581F-4C22-A5BD-4423492C79A9Q30488610-DC48210D-5E73-4EEE-B996-ED75355EC44BQ34269340-23D5739F-A2E2-4DD9-A4D9-1B36977CA655Q38222814-621A5DE9-2E99-4EF3-BD76-452DB45079F5Q40028395-A92646A2-FF2B-460F-9281-491A13A19FECQ41811282-6AA0B3C8-5477-49D5-AFB5-298C45A75AF6Q42071980-7598AA2F-1967-47D9-9997-27D30B2B2707Q45300850-93EA134D-0C4C-44DF-A9A0-ADFCB96BABDAQ46791403-1FF1FBA6-1C7F-40FA-A247-9CFED7BC0F71Q46942207-488328A1-093B-4F24-9269-3B209AA6F88AQ51743409-B0365B06-E5CB-4BBD-88BB-21924A2310DFQ58291143-0CDF7F52-FA7B-414E-8E37-5064A8709C6E
P2860
Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Neuroprotective effects of the ...... direct NMDA blocking activity.
@en
Neuroprotective effects of the ...... direct NMDA blocking activity.
@nl
type
label
Neuroprotective effects of the ...... direct NMDA blocking activity.
@en
Neuroprotective effects of the ...... direct NMDA blocking activity.
@nl
prefLabel
Neuroprotective effects of the ...... direct NMDA blocking activity.
@en
Neuroprotective effects of the ...... direct NMDA blocking activity.
@nl
P2093
P2860
P1476
Neuroprotective effects of the ...... direct NMDA blocking activity.
@en
P2093
Annita Pintor
Antonella Pèzzola
Claudio Frank
Luisa Minghetti
Maria Anna De Berardinis
Maria Rosaria Domenici
Maria Teresa Tebano
Marino Massotti
Patrizia Popoli
Rita Pepponi
P2860
P304
P356
10.1111/J.1471-4159.2004.02448.X
P407
P577
2004-06-01T00:00:00Z